We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Spark Holland Enters into new Partnership with DiLab for Automated Blood Sampling in Pharmacokinetic Studies
News

Spark Holland Enters into new Partnership with DiLab for Automated Blood Sampling in Pharmacokinetic Studies

Spark Holland Enters into new Partnership with DiLab for Automated Blood Sampling in Pharmacokinetic Studies
News

Spark Holland Enters into new Partnership with DiLab for Automated Blood Sampling in Pharmacokinetic Studies

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Spark Holland Enters into new Partnership with DiLab for Automated Blood Sampling in Pharmacokinetic Studies"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The AccuSampler Micro permits automated serial withdrawal of blood samples as small as 5µl up to 50µl from small lab animals, such as mice, for pharmacokinetic studies.  Adaptation of the AccuSampler will enable users to place Symbiosis trays with blood collection cartridges in the AccuSampler.  Trays with collected blood samples can then be placed directly in the Symbiosis system for online SPE-LC-MS analysis, without any further manual sample work-up.  The combination of collecting accurately measured small blood volumes and direct processing for online SPE-LC-MS allows serial blood sampling from small lab animals such as rats and mice, for an entire pharmacokinetic study with a single animal.  Not only will this significantly reduce the number of lab animals, but it also results in better pharmacokinetic data. In addition, throughput of pharmacokinetic studies is enhanced while providing more safety and less operator errors.

The DiLab ABS AccuSampler Micro is compliant with the “3R” guidelines for animal welfare as issued by the National Center for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) in London.

Advertisement